Mental Health Clinics in Lady Lake, FL Accepting Medicare
9 Mental Health Clinics found. Showing 1 - 9
 Neuropsychiatry Centers Llc Clinical Neuropsychologist Medicare: Medicare Enrolled Practice Location: 809 County Road 466 Ste 101-c, Lady Lake, FL 32159 Phone: 352-330-2020 Fax: 352-360-6582 |
Serenity Hope Consulting Services Inc Counseling And Therapy Clinic - Mental Health Medicare: Not Enrolled in Medicare Practice Location: 13940 N Us Highway 441 Ste 210, Lady Lake, FL 32159 Phone: 919-946-0143 |
Freedom Counseling Services, Llc Counselor - Mental Health Medicare: Medicare Enrolled Practice Location: 379 Fennell Blvd., Lady Lake, FL 32159 Phone: 352-633-5253 |
Mental Health Of Central Florida, Llc Clinic - Mental Health Medicare: Medicare Enrolled Practice Location: 929 N Us Highway 441 Ste 102, Lady Lake, FL 32159 Phone: 352-633-0473 Fax: 352-775-9562 |
Valencia Neurospina Center Pa Psychiatry & Neurology - Neurology Medicare: Not Enrolled in Medicare Practice Location: 729 County Road 466, Lady Lake, FL 32159 Phone: 352-633-1880 Fax: 352-633-1882 |
Village Neurology Center Psychiatry & Neurology - Neurology Medicare: Medicare Enrolled Practice Location: 729 Cr 466, Lady Lake, FL 32159 Phone: 352-633-2164 Fax: 352-205-8149 |
Villages Mind And Body Institute Counselor - Addiction (Substance Use Disorder) Medicare: Not Enrolled in Medicare Practice Location: 324 S Us Highway 441, Lady Lake, FL 32159 Phone: 352-633-0614 Fax: 866-684-9990 |
Center For Hope And Healing, Llc Social Worker - Clinical Medicare: Medicare Enrolled Practice Location: 804 Hwy 466, Lady Lake, FL 32159 Phone: 651-895-7621 |
Clinical Psychotherapy And Coaching Services Llc Social Worker - Clinical Medicare: Not Enrolled in Medicare Practice Location: 607 Highway 466 Ste C, Lady Lake, FL 32159 Phone: 352-450-7535 |
News Archive
Single-dose of experimental malaria drug clears parasites in mice, represents potential new class of drugs to treat malaria in humans
An experimental malaria drug was shown to effectively treat the disease in mice with only a single dose, according to a study published Thursday in the journal Science, Reuters reports (Kelland, 9/2). The new drug, known as NITD609, "represents an entirely new class of medicines to treat malaria ... Human trials, backed by Swiss pharmaceutical giant Novartis AG, could begin later this year," the Wall Street Journal writes (Naik, 9/3).
Genetic syndrome may underlie some Parkinson's cases
Rare deletions at chromosome 22q11.2 are present at an increased rate in patients with Parkinson's disease, researchers report in The Lancet Neurology.
Ohio State's Wexner Medical Center neurosurgeons implant MRI-safe spinal cord stimulator for pain
Neurosurgeons at The Ohio State University Wexner Medical Center are among the first in the United States to successfully implant an MRI-safe spinal cord stimulator to help patients suffering from chronic back or limb pain.
Researchers discover how distant satellite cells could help repair damaged muscles
When a muscle is damaged, dormant adult stem cells called satellite cells are signaled to "wake up" and contribute to repairing the muscle. University of Missouri researchers recently found how even distant satellite cells could help with the repair, and are now learning how the stem cells travel within the tissue.
FDA approves CSL Behring's Hizentra for PI
CSL Behring announced today that the U.S. Food and Drug Administration (FDA) has granted marketing approval for HizentraTM, Immune Globulin Subcutaneous (Human), 20% Liquid, for treating patients diagnosed with primary immunodeficiency (PI). A once weekly immunoglobulin (Ig) replacement therapy, Hizentra provides effective protection against infection by maintaining a steady and normal level of immunoglobulin in the body.
› Verified 4 days ago